Skip to main content
Erschienen in: Surgery Today 11/2015

01.11.2015 | Original Article

Risk factors for a persistent type 2 endoleak after endovascular aneurysm repair

verfasst von: Toshiyuki Maeda, Toshiro Ito, Yoshihiko Kurimoto, Toshitaka Watanabe, Yohsuke Kuroda, Nobuyoshi Kawaharada, Tetsuya Higami

Erschienen in: Surgery Today | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the natural course of type 2 endoleaks (T2Es) and to identify the risk factors associated with a persistent T2E after endovascular aneurysm repair (EVAR).

Methods

The medical records of patients who underwent EVAR for the treatment of an atherosclerotic abdominal aortic aneurysm between October 2006 and December 2011 at our institute were reviewed. T2Es were diagnosed by contrast-enhanced computed tomography within 4 weeks of EVAR, and patients were followed up at 6 and 12 months. In cases where a T2E was detected, the blood vessels responsible for the T2E were identified and statistically analyzed for their association with a persistent T2E.

Results

We identified T2Es in 111 of 469 patients within 4 weeks of undergoing EVAR. During the follow-up, 41 patients (36.9 %) showed spontaneous resolution of their T2E. The percentage of patients with a T2E was 75.4, 69.2 and 58.0 % at 6, 12 and 24 months, respectively. T2E caused by defects in multiple vessels and T2E associated with the fourth lumbar artery were identified as risk factors associated with a persistent T2E in the univariate analysis. In the multivariate analysis, T2E caused by multiple vessels was identified as the only independent risk factor for a persistent T2E.

Conclusions

We identified T2E caused by multiple vessel failure as an independent risk factor for persistent T2E.
Literatur
1.
Zurück zum Zitat El Batti S, Cochennec Frédéric, Roudot-Thoraval Françoise, Becquemin Jean-Pierre. Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg. 2013;57:1291–8.CrossRefPubMed El Batti S, Cochennec Frédéric, Roudot-Thoraval Françoise, Becquemin Jean-Pierre. Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg. 2013;57:1291–8.CrossRefPubMed
2.
Zurück zum Zitat Nolz R, Teufelsbauer H, Asenbaum U, Beitzke D, Funovics M, Wibmer A, et al. Type II endoleaks after endovascular repair of abdominal aortic aneurysms: fate of the aneurysm sac and neck changes during long-term follow-up. J Endovasc Ther. 2012;19:193–9.CrossRefPubMed Nolz R, Teufelsbauer H, Asenbaum U, Beitzke D, Funovics M, Wibmer A, et al. Type II endoleaks after endovascular repair of abdominal aortic aneurysms: fate of the aneurysm sac and neck changes during long-term follow-up. J Endovasc Ther. 2012;19:193–9.CrossRefPubMed
3.
Zurück zum Zitat Jones JE, Atkins MD, Brewster DC, Chung TK, Kwolek CJ, LaMuraglia GM, et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg. 2007;46:1–8.CrossRefPubMed Jones JE, Atkins MD, Brewster DC, Chung TK, Kwolek CJ, LaMuraglia GM, et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg. 2007;46:1–8.CrossRefPubMed
4.
Zurück zum Zitat Steinmetz E, Rubin BG, Sanchez LA, Choi ET, Geraghty PJ, Baty J, et al. TypeIIendoleak after endovascular abdominal aortic aneurysm repair: A conservative approach with selective intervention is safe and cost-effective. J Vasc Surg. 2004;39:306–13.CrossRefPubMed Steinmetz E, Rubin BG, Sanchez LA, Choi ET, Geraghty PJ, Baty J, et al. TypeIIendoleak after endovascular abdominal aortic aneurysm repair: A conservative approach with selective intervention is safe and cost-effective. J Vasc Surg. 2004;39:306–13.CrossRefPubMed
5.
Zurück zum Zitat Timaran CH, Ohki T, Rhee SJ, Veith FJ, Gargiulo NJ III, Toriumi H, et al. Predicting aneurysm enlargement in patients with persistent type II endoleaks. J Vasc Surg. 2004;39:1157–62.CrossRefPubMed Timaran CH, Ohki T, Rhee SJ, Veith FJ, Gargiulo NJ III, Toriumi H, et al. Predicting aneurysm enlargement in patients with persistent type II endoleaks. J Vasc Surg. 2004;39:1157–62.CrossRefPubMed
6.
Zurück zum Zitat Kodama A, Narita H, Kobayashi M, Yamamoto K, Komori K, et al. Usefulness of POSSUM physiological score for the estimation of morbidity and mortality risk after elective abdominal aortic aneurysm repair in Japan. Circ J. 2011;75:550–6.CrossRefPubMed Kodama A, Narita H, Kobayashi M, Yamamoto K, Komori K, et al. Usefulness of POSSUM physiological score for the estimation of morbidity and mortality risk after elective abdominal aortic aneurysm repair in Japan. Circ J. 2011;75:550–6.CrossRefPubMed
7.
Zurück zum Zitat Schermerhorn ML, O’Malley AJ, Jhaveri A, Cotterill P, Pomposelli F, Landon BE. Endovascular vs. open repair of abdominal aortic aneurysms in the medicare population. N Engl J Med. 2008;358:464–74.CrossRefPubMed Schermerhorn ML, O’Malley AJ, Jhaveri A, Cotterill P, Pomposelli F, Landon BE. Endovascular vs. open repair of abdominal aortic aneurysms in the medicare population. N Engl J Med. 2008;358:464–74.CrossRefPubMed
8.
Zurück zum Zitat Harris PL, Vallabhaneni SR, Desgranges P, Becquemin JP, van Marrewijk C, Laheij RJF, for the EUROSTAR Collaborators. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg. 2000;32:739–49. Harris PL, Vallabhaneni SR, Desgranges P, Becquemin JP, van Marrewijk C, Laheij RJF, for the EUROSTAR Collaborators. Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg. 2000;32:739–49.
9.
Zurück zum Zitat Silverberg D, Baril DT, Ellozy SH, Carroccio A, Greyrose SE, Lookstein RA, et al. An 8-year experience with type II endoleaks: natural history suggests selective intervention is a safe approach. J Vasc Surg. 2006;44:453–9.CrossRefPubMed Silverberg D, Baril DT, Ellozy SH, Carroccio A, Greyrose SE, Lookstein RA, et al. An 8-year experience with type II endoleaks: natural history suggests selective intervention is a safe approach. J Vasc Surg. 2006;44:453–9.CrossRefPubMed
10.
Zurück zum Zitat Tuerff SN, Rockman CB, Lamparello PJ, Adelman MA, Jacobowitz GR, et al. Are typeII(branch vessel) endoleaks really benign? Ann Vasc Surg. 2002;16:50–4.CrossRefPubMed Tuerff SN, Rockman CB, Lamparello PJ, Adelman MA, Jacobowitz GR, et al. Are typeII(branch vessel) endoleaks really benign? Ann Vasc Surg. 2002;16:50–4.CrossRefPubMed
11.
Zurück zum Zitat Abularrage CJ, Crawford RS, Conrad MF, Lee H, Kwolek CJ, Brewster DC, et al. Preoperative variables predict persistent type 2 endoleak after endovascular aneurysm repair. J Vasc Surg. 2010;52:19–24.CrossRefPubMed Abularrage CJ, Crawford RS, Conrad MF, Lee H, Kwolek CJ, Brewster DC, et al. Preoperative variables predict persistent type 2 endoleak after endovascular aneurysm repair. J Vasc Surg. 2010;52:19–24.CrossRefPubMed
12.
Zurück zum Zitat Marchiori A, Ristow A, Guimaraes M, Scho¨nholz C, Uflacker R. Predictive factors for the development of type ii endoleaks. J Endovasc Ther. 2011;18:299–305. Marchiori A, Ristow A, Guimaraes M, Scho¨nholz C, Uflacker R. Predictive factors for the development of type ii endoleaks. J Endovasc Ther. 2011;18:299–305.
13.
Zurück zum Zitat AbuRahma AF, Mousa AY, Campbell JE, Stone PA, Hass SM, Nanjundappa A, et al. The relationship of preoperative thrombus load and location to the development of type II endoleak and sac regression. J Vasc Surg. 2011;53:1534–41.CrossRefPubMed AbuRahma AF, Mousa AY, Campbell JE, Stone PA, Hass SM, Nanjundappa A, et al. The relationship of preoperative thrombus load and location to the development of type II endoleak and sac regression. J Vasc Surg. 2011;53:1534–41.CrossRefPubMed
14.
Zurück zum Zitat Bobadilla JL, Hoch JR, Leverson GE, Tefera G. The effect of warfarin therapy on endoleak development after endovascular aneurysm repair (EVAR) of the abdominal aorta. J Vasc Surg. 2010;52:267–71.CrossRefPubMed Bobadilla JL, Hoch JR, Leverson GE, Tefera G. The effect of warfarin therapy on endoleak development after endovascular aneurysm repair (EVAR) of the abdominal aorta. J Vasc Surg. 2010;52:267–71.CrossRefPubMed
15.
Zurück zum Zitat Beeman BR, Murtha Kathy, Doerr K, McAfee-Bennett S, Dougherty MJ, Calligaro KD. Duplex ultrasound factors predicting persistent type II endoleak and increasing AAA sac diameter after EVAR. J Vasc Surg. 2010;52:1147–52.CrossRefPubMed Beeman BR, Murtha Kathy, Doerr K, McAfee-Bennett S, Dougherty MJ, Calligaro KD. Duplex ultrasound factors predicting persistent type II endoleak and increasing AAA sac diameter after EVAR. J Vasc Surg. 2010;52:1147–52.CrossRefPubMed
16.
Zurück zum Zitat Arko FR, Rubin GD, Johnson BL, Hill BB, Fogarty TJ, Zarins CK. Type-II endoleaks following endovascular aaa repair: preoperative predictors and long-term effects. J Endovasc Ther. 2001;8:503–10.CrossRefPubMed Arko FR, Rubin GD, Johnson BL, Hill BB, Fogarty TJ, Zarins CK. Type-II endoleaks following endovascular aaa repair: preoperative predictors and long-term effects. J Endovasc Ther. 2001;8:503–10.CrossRefPubMed
17.
Zurück zum Zitat Koyanagi T, Kawaharada N, Kurimoto Y, Ito T, Baba T, Nakamura M, et al. Examination of intercostal arteries with transthoracic Doppler sonography. Echocardiography. 2010;27:17–20.CrossRefPubMed Koyanagi T, Kawaharada N, Kurimoto Y, Ito T, Baba T, Nakamura M, et al. Examination of intercostal arteries with transthoracic Doppler sonography. Echocardiography. 2010;27:17–20.CrossRefPubMed
18.
Zurück zum Zitat Kasirajan K, Matteson B, Marek JM, Langsfeld M. Technique and results of transfemoral superselective coil embolization of type II lumbar endoleak. J Vasc Surg. 2003;38:61–6.CrossRefPubMed Kasirajan K, Matteson B, Marek JM, Langsfeld M. Technique and results of transfemoral superselective coil embolization of type II lumbar endoleak. J Vasc Surg. 2003;38:61–6.CrossRefPubMed
19.
Zurück zum Zitat Abularrage CJ, Patel VI, Conrad MF, Schneider EB, Cambria RP, Kwolek CJ. Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair. J Vasc Surg. 2012;56:630–6.CrossRefPubMed Abularrage CJ, Patel VI, Conrad MF, Schneider EB, Cambria RP, Kwolek CJ. Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair. J Vasc Surg. 2012;56:630–6.CrossRefPubMed
20.
Zurück zum Zitat Solis MM, Ayerdi J, Babcock GA, Parra JR, McLafferty RB, Gruneiro LA, et al. Mechanism of failure in the treatment of type II endoleak with percutaneous coil embolization. J Vasc Surg. 2002;36:485–91. Solis MM, Ayerdi J, Babcock GA, Parra JR, McLafferty RB, Gruneiro LA, et al. Mechanism of failure in the treatment of type II endoleak with percutaneous coil embolization. J Vasc Surg. 2002;36:485–91.
Metadaten
Titel
Risk factors for a persistent type 2 endoleak after endovascular aneurysm repair
verfasst von
Toshiyuki Maeda
Toshiro Ito
Yoshihiko Kurimoto
Toshitaka Watanabe
Yohsuke Kuroda
Nobuyoshi Kawaharada
Tetsuya Higami
Publikationsdatum
01.11.2015
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 11/2015
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-1070-6

Weitere Artikel der Ausgabe 11/2015

Surgery Today 11/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.